Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Revenue: | ||||
| Interest on finance receivables | $ 147,652 | $ 153,706 | $ 441,904 | $ 433,968 |
| Other revenue | 1,578 | 1,383 | 4,377 | 3,832 |
| Interest and other income | 149,230 | 155,089 | 446,281 | 437,800 |
| Change in fair value of finance receivables | (56,476) | (50,532) | (180,058) | (142,187) |
| Net revenue | 92,754 | 104,557 | 266,223 | 295,613 |
| Expenses: | ||||
| Salaries and employee benefits | 12,718 | 14,513 | 43,266 | 46,045 |
| Direct marketing costs | 13,044 | 14,514 | 34,832 | 36,692 |
| Professional fees | 7,538 | 6,100 | 28,415 | 15,091 |
| Interest expense and amortized debt issuance costs | 8,659 | 10,079 | 25,294 | 29,965 |
| Technology costs | 3,934 | 3,131 | 10,788 | 9,474 |
| Payment processing fees | 1,675 | 1,712 | 4,967 | 4,869 |
| Depreciation and amortization | 1,945 | 1,133 | 4,045 | 4,395 |
| Occupancy | 985 | 1,030 | 2,843 | 3,099 |
| General, administrative and other | 5,212 | 3,900 | 15,012 | 10,238 |
| Total expenses | 55,710 | 56,112 | 169,462 | 159,868 |
| Income from operations | 37,044 | 48,445 | 96,761 | 135,745 |
| Other income (expense): | ||||
| Change in fair value of warrant liabilities | 2,842 | 31,688 | 24,338 | (23,223) |
| Income from equity method investment | 774 | 1,365 | 2,707 | 3,562 |
| Other income | 86 | 82 | 405 | 241 |
| Income before income taxes | 40,746 | 81,580 | 124,211 | 116,325 |
| Income tax expense | 6,267 | 5,647 | 20,082 | 8,522 |
| Net income | 34,479 | 75,933 | 104,129 | 107,803 |
| Less: net income attributable to noncontrolling interest | 0 | 34,298 | 26,407 | 98,320 |
| Net income attributable to OppFi Inc. | $ 34,479 | $ 41,635 | $ 77,722 | $ 9,483 |
| Earnings per common share: | ||||
| Basic (in dollars per share) | $ 0.41 | $ 1.48 | $ 1.29 | $ 0.36 |
| Diluted (in dollars per share) | $ 0.40 | $ 0.77 | $ 1.14 | $ 0.36 |
| Weighted average common shares outstanding: | ||||
| Basic (in shares) | 85,066,885 | 28,163,404 | 60,027,387 | 26,168,321 |
| Diluted (in shares) | 85,571,877 | 88,236,591 | 85,933,941 | 26,168,321 |
| X | ||||||||||
- Definition Gain (loss) due to change in fair value of finance receivables. No definition available.
|
| X | ||||||||||
- Definition Interest expense and amortized debt issuance costs. No definition available.
|
| X | ||||||||||
- Definition Payment processing fees. No definition available.
|
| X | ||||||||||
- Definition Technology Costs No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total aggregate amount of all noninterest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|